Prevalence and correlates of jugular injections among injection drug users

References

• McCoy C B, Rodriguez F. Global overview of injecting drug use and HIV infection. Lancet 2005; 365: 1008–1009
   PubMed Web of Science ®Google Scholar
• Sherman S G, Fuller C M, Shah N, Ompad D V, Vlahov D, Strathdee S A. Correlates of initiation of injection drug use among young drug users in Baltimore, Maryland: the need for early intervention. J Psychoact Drugs 2005; 37: 437–443
   PubMed Web of Science ®Google Scholar
• Heimer R, Kaplan E H, Khoshnood K, Jariwala B, Cadman E C. Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut. Am J Med 1993; 95: 214–220
   PubMed Web of Science ®Google Scholar
• Kral A H, Bluthenthal R N, Erringer E A, Lorvick J, Edlin B R. Risk factors among IDUs who give injections to or receive injections from other drug users. Addiction 1999; 94: 675–683
   PubMed Web of Science ®Google Scholar
• Binswanger I A, Kral A H, Bluthenthal R N, Rybold D J, Edlin B R. High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin Infect Dis 2000; 30: 579–581
   PubMed Web of Science ®Google Scholar
• Lloyd-Smith E, Kerr T, Hogg R S, Li K, Montaner J S, Wood E. Prevalence and correlates of abscesses among a cohort of injection drug users. Harm Reduct J 2005; 2: 24
   PubMedGoogle Scholar
• Maggi P, Fullone M, Federico M, Angarano G, Pastore G, Regina G. Drug injection in jugular veins: a new risk factor for vascular diseases in HIV-infected patients? A case report. Angiology 1995; 46: 1049–1052
   PubMed Web of Science ®Google Scholar
• Wood E, Spittal P M, Kerr T, et al. Requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: implications for HIV prevention. Can J Public Health 2003; 94: 355–359
   PubMed Web of Science ®Google Scholar
• Myers E M, Kirkland L S, Jr, Mickey R. The head and neck sequelae of cervical intravenous drug abuse. Laryngoscope 1988; 98: 213–218
   PubMed Web of Science ®Google Scholar
• Mesquita F, Kral A, Reingold A, Bueno R, Trigueiros D, Araujo P J. Trends of HIV infection among injection drug users in Brazil in the 1990s: the impact of changes in patterns of drug use. J Acquir Immune Defic Syndr 2001; 28: 298–302
   PubMed Web of Science ®Google Scholar
• Sheikh M A, Topoulos A P, Deitcher S R. Isolated internal jugular vein thrombosis: risk factors and natural history. Vasc Med 2002; 7: 177–179
   PubMed Web of Science ®Google Scholar
• Lin D, Reeck J B, Murr A H. Internal jugular vein thrombosis and deep neck infection from intravenous drug use: management strategy. Laryngoscope 2004; 114: 56–60
   PubMed Web of Science ®Google Scholar
• Chowdhury K, Bloom J, Black M J, al-Noury K. Spontaneous and nonspontaneous internal jugular vein thrombosis. Head Neck 1990; 12: 168–173
   PubMed Web of Science ®Google Scholar
• Jackson A L, Cornwell E, III, Daniels F. Hemopneumothorax in an intravenous drug abuser. J Natl Med Assoc 1995; 87: 309–311
   PubMed Web of Science ®Google Scholar
• Bell C, Borak J, Loeffler J R. Pneumothorax in drug abusers: a complication of internal jugular venous injections. Ann Emerg Med 1983; 12: 167–170
   PubMed Web of Science ®Google Scholar
• Angelos M G, Sheets C A, Zych P R. Needle emboli to lung following intravenous drug abuse. J Emerg Med 1986; 4: 391–396
   PubMedGoogle Scholar
• Raz S, Ramanathan V. Injection injuries of the recurrent laryngeal nerve. Laryngoscope 1984; 94: 197–200
   PubMed Web of Science ®Google Scholar
• Cohen J P, Persky M S, Reede D L. Internal jugular vein thrombosis. Laryngoscope 1985; 95: 1478–1482
   PubMed Web of Science ®Google Scholar
• Lewis J W, Jr, Groux N, Elliott J P, Jr, Jara F M, Obeid F N, Magilligan D J, Jr. Complications of attempted central venous injections performed by drug abusers. Chest 1980; 78: 613–617
   PubMed Web of Science ®Google Scholar
• Strathdee S A, Patrick D M, Currie S L, et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS 1997; 11: F59–65
   PubMed Web of Science ®Google Scholar
• Kerr T, Tyndall M, Li K, Montaner J S, Wood E. Safer injection facility use and syringe sharing in injection drug users. Lancet 2005; 366: 316–318
   PubMed Web of Science ®Google Scholar
• Palepu A, Tyndall M W, Leon H, et al. Hospital utilization and costs in a cohort of injection drug users. Can Med Assoc J 2001; 165: 415–420
   PubMed Web of Science ®Google Scholar
• Wood E, Li K, Small W, Montaner J S, Schechter M T, Kerr T. Recent incarceration independently associated with syringe sharing by injection drug users. Public Health Rep 2005; 120: 150–156
   PubMed Web of Science ®Google Scholar
• Wood E, Tyndall M, Stoltz J, et al. Safer injecting education for HIV prevention within a medically supervised safer injecting facility. Int J Drug Pol 2005; 16: 281–284
   Web of Science ®Google Scholar
• O'Connell J, Kerr T, Li K, et al. Requiring help injecting independently predicts incident HIV infection among injection drug users. J AIDS 2005; 40: 83–88
   PubMed Web of Science ®Google Scholar
• Miller C L, Strathdee S A, Li K, Kerr T, Wood E. A longitudinal investigation into excess risk for blood-borne infection among young injection drug users (IUDs). Am J Drug Alcohol Abuse 2007; 33: 527–536
   PubMed Web of Science ®Google Scholar
• Des Jarlais D C, Paone D, Milliken J, et al. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet 1999; 353: 1657–1661
   PubMed Web of Science ®Google Scholar